Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gh Research Plc (NQ: GHRS )

7.600 -0.330 (-4.16%)
Streaming Delayed Price Updated: 3:53 PM EDT, Mar 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Gh Research Plc

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
GH Research, Cybin Among Top Psychedelic Movers Of Today
 
Via Benzinga
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50. 
Via Benzinga
ADMA Biologics, C3.ai And Other Big Stocks Moving Higher On Friday
U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
GH Resources: Focus On Treatment-Resistant Depression Paying Off
A look at what GH Research is focused on, its latest quarterly financials, its stock price performance, and the price forecasts for the stock over the next 12 months. 
Via Talk Markets
GH Research, Compass Pathways Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 22, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 21, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 20, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 17, 2023
 
Via Benzinga
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
 
Via Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
 
Via Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
 
Via Benzinga
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
 
Via Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 9, 2023
 
Via Benzinga
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today
 
Via Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
Psychedelics Bills Around The Country: 9 New Proposals, Several Passes, Several Fails And A Successful Local Decriminalization Throughout the 2023 session, numerous discussions have been... 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 6, 2023
 
Via Benzinga
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.   
Via Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
GH Research 2022 R&D Expenses Grow 138% To $20.5M, What About Net Loss?
GH Research PLC (NASDAQ: GHRS) released its financial results for the full year ended December 31, 2022, revealing R&D expenses were $20.5 million, a 138% increase compared to $8.6 million for the full... 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 2, 2023
 
Via Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 28, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 27, 2023
 
Via Benzinga
Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD
The most critical financial information on the health of a company is whether, or not, it has a Net Positive Operating Cash Flow; its Altman -Z Score; its Piotroski F-Score; and the percentage... 
Via Talk Markets
Psychedelic Stock Gainers And Losers From February 24, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 23, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 22, 2023
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.